Molecular Formula | C16H12N4O |
Molar Mass | 276.29 |
Density | 1.37±0.1 g/cm3(Predicted) |
Boling Point | 585.3±50.0 °C(Predicted) |
pKa | 10.83±0.50(Predicted) |
Storage Condition | Keep in dark place,Inert atmosphere,Room temperature |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.619 ml | 18.097 ml | 36.194 ml |
5 mM | 0.724 ml | 3.619 ml | 7.239 ml |
10 mM | 0.362 ml | 1.81 ml | 3.619 ml |
5 mM | 0.072 ml | 0.362 ml | 0.724 ml |
Use | 3-amino-5-(4-phenoxyphenyl)-4-cyano-1H-pyrazole is used to synthesize ibrutinib An intermediate, ibrutinib is a Bruton tyrosine kinase (BTK) inhibitor, used to treat chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). Ibrutinib can be combined with BTK targeting, which is necessary for the formation, differentiation, information transmission and survival of B lymphocytes, irreversibly inhibit the activity of BTK, and effectively inhibit the proliferation and survival of tumor cells. |